Zobrazeno 1 - 9
of 9
pro vyhledávání: '"van der Windt GJW"'
Autor:
van Bruggen JAC; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Peters FS; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Mes M; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Rietveld JM; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Cerretani E; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Cretenet G; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., van Kampen R; Zuyderland Medical Center, Sittard-Geleen, The Netherlands., Jongejan A; Department of Epidemiology and Data Science, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Moerland PD; Department of Epidemiology and Data Science, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Melenhorst JJ; Cleveland Clinic, Lerner Research Institute, Center for Immunotherapy & Precision Immuno-Oncology, Cleveland, OH., van der Windt GJW; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Eldering E; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Kater AP; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Blood advances [Blood Adv] 2024 Sep 10; Vol. 8 (17), pp. 4633-4646.
Autor:
Martens AWJ; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Meibergdreef 9, Amsterdam, The Netherlands., Kavazović I; Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia., Krapić M; Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia., Pack SM; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Meibergdreef 9, Amsterdam, The Netherlands., Arens R; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Jongejan A; Department of Epidemiology and Data Science, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Moerland PD; Department of Epidemiology and Data Science, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Eldering E; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Meibergdreef 9, Amsterdam, The Netherlands., van der Windt GJW; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Meibergdreef 9, Amsterdam, The Netherlands., Wensveen FM; Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia., Peters FS; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Meibergdreef 9, Amsterdam, The Netherlands., Kater AP; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. a.p.kater@amsterdamumc.nl.
Publikováno v:
Leukemia [Leukemia] 2023 Mar; Vol. 37 (3), pp. 606-616. Date of Electronic Publication: 2023 Jan 19.
Autor:
Chen Z; Experimental Immunology, and.; Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, The Netherlands., Simon-Molas H; Experimental Immunology, and.; Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, The Netherlands., Cretenet G; Experimental Immunology, and.; Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, The Netherlands., Valle-Argos B; Curve Therapeutics, University of Southampton, Southampton, UK.; Cancer Research UK Centre, Cancer Sciences, University of Southampton, Southampton, UK., Smith LD; Cancer Research UK Centre, Cancer Sciences, University of Southampton, Southampton, UK.; Ploughshare Innovations Limited, Porton Science Park, Porton Down, UK., Forconi F; Department of Haematology, Southampton University Hospital Trust, Southampton, UK., Schomakers BV; Laboratory Genetic Metabolic Diseases, and.; Core Facility Metabolomics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands., van Weeghel M; Laboratory Genetic Metabolic Diseases, and.; Core Facility Metabolomics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands., Bryant DJ; Cancer Research UK Centre, Cancer Sciences, University of Southampton, Southampton, UK., van Bruggen JAC; Experimental Immunology, and.; Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, The Netherlands., Peters FS; Experimental Immunology, and.; Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, The Netherlands., Rathmell JC; Vanderbilt Center for Immunobiology, Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN., van der Windt GJW; Genmab, Utrecht, The Netherlands; and., Kater AP; Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center, Amsterdam, The Netherlands., Packham G; Cancer Research UK Centre, Cancer Sciences, University of Southampton, Southampton, UK., Eldering E; Experimental Immunology, and.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center, Amsterdam, The Netherlands.
Publikováno v:
Blood [Blood] 2022 Aug 11; Vol. 140 (6), pp. 630-643.
Autor:
van Bruggen JAC; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands; and., van der Windt GJW; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands; and., Hoogendoorn M; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Dubois J; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands; and., Kater AP; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands; and., Peters FS; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands; and.
Publikováno v:
Blood advances [Blood Adv] 2022 Jul 26; Vol. 6 (14), pp. 4185-4195.
Autor:
Martens AWJ; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Amsterdam, The Netherlands.; Department of Hematology, Cancer Center Amsterdam and Lymphoma and Myeloma Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands., Janssen SR; Department of Hematology, Cancer Center Amsterdam and Lymphoma and Myeloma Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands., Derks IAM; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Amsterdam, The Netherlands., Adams Iii HC; Janssen Pharmaceutical Companies of Johnson and Johnson, Philadelphia, Pennsylvania, USA., Izhak L; Janssen Pharmaceutical Companies of Johnson and Johnson, Philadelphia, Pennsylvania, USA., van Kampen R; Department of Internal Medicine, Zuyderland Medical Centre Heerlen, Heerlen, The Netherlands., Tonino SH; Department of Hematology, Cancer Center Amsterdam and Lymphoma and Myeloma Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands., Eldering E; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Amsterdam, The Netherlands., van der Windt GJW; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Amsterdam, The Netherlands.; Department of Hematology, Cancer Center Amsterdam and Lymphoma and Myeloma Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands., Kater AP; Department of Hematology, Cancer Center Amsterdam and Lymphoma and Myeloma Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands a.p.kater@amsterdamumc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Jun; Vol. 8 (1).
Autor:
van Bruggen JAC; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, The Netherlands., Martens AWJ; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, The Netherlands., Fraietta JA; Department of Pathology and Laboratory Medicine.; Department of Microbiology.; Center for Cellular Immunotherapies, and.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Hofland T; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, The Netherlands., Tonino SH; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and., Eldering E; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, The Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Siska PJ; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany; and., Endstra S; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, The Netherlands., Rathmell JC; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN., June CH; Department of Pathology and Laboratory Medicine.; Center for Cellular Immunotherapies, and., Porter DL; Department of Pathology and Laboratory Medicine., Melenhorst JJ; Department of Pathology and Laboratory Medicine.; Center for Cellular Immunotherapies, and., Kater AP; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and., van der Windt GJW; Department of Hematology, Cancer Center Amsterdam.; Lymphoma and Myeloma Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, The Netherlands.
Publikováno v:
Blood [Blood] 2019 Jul 04; Vol. 134 (1), pp. 44-58. Date of Electronic Publication: 2019 May 10.
Autor:
Van den Bossche J; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Amsterdam Cardiovascular Sciences, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, the Netherlands. Electronic address: j.vandenbossche@vumc.nl., van der Windt GJW; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Infection and Immunity, Meibergdreef 9, Amsterdam, the Netherlands.
Publikováno v:
Cell metabolism [Cell Metab] 2018 Oct 02; Vol. 28 (4), pp. 538-540.
Autor:
O'Sullivan D, van der Windt GJW, Huang SC, Curtis JD, Chang CH, Buck MD, Qiu J, Smith AM, Lam WY, DiPlato LM, Hsu FF, Birnbaum MJ, Pearce EJ, Pearce EL
Publikováno v:
Immunity [Immunity] 2018 Aug 21; Vol. 49 (2), pp. 375-376.
Autor:
van der Windt GJW; Department of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Chang CH; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USA., Pearce EL; Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Publikováno v:
Current protocols in immunology [Curr Protoc Immunol] 2016 Apr 01; Vol. 113, pp. 3.16B.1-3.16B.14. Date of Electronic Publication: 2016 Apr 01.